Business Context and Reporting Period
This Form 8-K was filed by Complete Solaria, Inc., not SunPower Inc., for an event occurring on May 13, 2024. The company is incorporated in Delaware and its common stock trades on Nasdaq under CSLR; its warrants trade under CSLRW.
Transaction and Key Financial Terms
- The company entered into a simple agreement for future equity (SAFE) with the Rodgers Massey Freedom and Free Markets Charitable Trust.
- The purchaser invested $1.0 million in the company.
- Upon an eligible equity financing, the SAFE converts into common stock at a price equal to 50% of the financing price per share.
- Based on an assumed conversion price of $0.275 per share, the SAFE could convert into a maximum of 2,750,000 common shares. The assumed price reflects 50% of the company’s May 13, 2024 closing share price of $0.55.
- If a change of control occurs before termination, the purchaser is entitled to a portion of the liquidity-event proceeds equal to $1.0 million, subject to specified adjustments.
Material Changes and Unusual Items
- The SAFE creates potential future equity dilution of up to 2,750,000 shares based on the stated assumptions.
- Thurman J. Rodgers is a trustee of the purchaser and also serves as the company’s Executive Chairman and Chief Executive Officer, making the transaction a related-party financing.
- The securities were issued in reliance on the private-placement exemptions under Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D.
Guidance, Outlook, Risks, and Contingencies
The filing provides no revenue, earnings, cash-flow, margin, debt, liquidity, or operating guidance. Key contingencies include the conversion terms in a future equity financing, the potential change-of-control payment, and the final number of shares issued, which may differ from the stated maximum.
Investor Verification Items
- Verify that the filing relates to Complete Solaria, Inc. rather than SunPower Inc.
- Review the complete SAFE filed as Exhibit 10.1 for conversion, termination, adjustment, and change-of-control provisions.
- Assess the potential dilution from the SAFE and any other outstanding convertible securities or warrants.
- Review the related-party nature of the transaction and the roles of Thurman J. Rodgers.
- Confirm the company’s subsequent equity financings, share issuance, and capitalization effects.